 |
인쇄하기
취소
|
KFDA to issue caution over prescription of weight loss pill sibutramine
Doctors will be advised to restrain the prescription of the controversial anti-obesity drug sibutramine in patients with cardiovascular disease, according to the Korea Food and Drug Administration.
The measures come following a recommendation from the Central Pharmaceutical Affairs Review Committee on January 29.
The KFDA said it has no intention to ban the sales of sibutramine, citing th...
The measures come following a recommendation from the Central Pharmaceutical Affairs Review Committee on January 29.
The KFDA said it has no intention to ban the sales of sibutramine, citing th...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.